In 2010, the world’s most expensive therapy was Soliris (eculizumab), costing around USD 409,500 p...
Read moreA €3 million invoice for a single infusion can dazzle as easily as it alarms. Gene therapies such ...
Read moreThe National Healthcare Security Administration (NHSA) of China completed its annual review of the N...
Read moreThe Saudi Food & Drug Authority (SFDA) released guidelines for Economic Evaluation Studies to assess...
Read moreWe summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...
Read moreAccording to the UICC, “priority will be given to medicines currently on the WHO Essential Medicin...
Read moreIntroduction For some manufacturers, launching in the Middle East and North Africa (MENA) is fraught...
Read moreIntroduction As the most populous country in the world with 1.4 billion inhabitants, China has the p...
Read moreIntroduction Health Technology Assessment (HTA) implementation has been historically slow in Asia co...
Read moreIntroduction: Brazil is a market of 210 million people Brazil is the largest country in South Americ...
Read more